Support & Resources

BACK

Enroll Now for CALQUENCECares

CALQUENCECares™ was created to provide you with education and support during treatment with CALQUENCE.

enroll

CALQUENCECares was created to provide you with education and support during treatment with CALQUENCE.

enroll

Enroll today and receive education and support, such as:

  • Information about treatment with CALQUENCE
  • Regular mailings or e-mails with helpful information
  • PLUS information on managing your treatment

It only takes a few minutes to complete the online registration for CALQUENCECares. Enroll now!

ACALA

Register for more information

*Indicates required field.

Stay up to date with the latest news and information about CALQUENCE® (acalabrutinib).

 
 I'm a patient taking or seeking information about CALQUENCE capsules.
 I care for someone taking or seeking information about CALQUENCE.
 
 
 
 
 
 Email
 Postal mail
 
 Yes
 No
 
 
 
 
 
 I would like to receive information in the future about all AstraZeneca products, programs, and that may be of interest to me.
 001
 
 

By clicking SUBMIT, you are certifying that you are 18 years or older and are signing another individual up to receive information from AstraZeneca about programs and services related to CALQUENCE.

We protect your information.

AstraZeneca respects your personal health information. The information you provide may be used to send you health-related materials and to develop products, services, and programs. AstraZeneca, or third parties working on our behalf, will not sell or rent personal health information. If, in the future, you no longer want to receive health-related materials, call 1-800-236-9933. Please visit www.azprivacynotice.com to review our Privacy Notice.


Back to top
+

IMPORTANT SAFETY INFORMATION

CALQUENCE may cause serious side effects, including:

  • Bleeding problems (hemorrhage) may happen during treatment with CALQUENCE, and can be serious. Your risk of bleeding may increase if you are also taking a blood thinner medicine. Tell your healthcare provider if you have any signs or symptoms of bleeding, including:
    • blood in your stools or black stools (looks like tar)
    • pink or brown urine
    • unexpected bleeding, or bleeding that is severe or you cannot control
    • vomit blood or vomit that looks like coffee grounds
    • cough up blood or blood clots
    • dizziness
    • weakness
    • confusion
    • change in your speech
    • headache that lasts a long time
  • Infections. Infections can happen during treatment with CALQUENCE. These infections can be serious and may lead to death. Tell your healthcare provider right away if you have fever, chills, or flu-like symptoms.
  • Decrease in blood cell counts. Decreased blood counts (white blood cells, platelets, and red blood cells) are common with CALQUENCE, but can also be severe. Your healthcare provider should do monthly blood tests to check your blood counts.
  • Second primary cancers. New cancers have happened in people during treatment with CALQUENCE, including cancers of the skin. Use sun protection when you are outside in sunlight.
  • Heart rhythm problems (atrial fibrillation and atrial flutter) have happened in people treated with CALQUENCE. Tell your healthcare provider if you have any of the following signs or symptoms:
    • your heartbeat is fast or irregular
    • feel lightheaded or dizzy
    • pass out (faint)
    • shortness of breath
    • chest discomfort

The most common side effects of CALQUENCE include:

  • headache
  • diarrhea
  • tiredness
  • muscle aches
  • bruising

These are not all the possible side effects of CALQUENCE. Call your doctor for medical advice about side effects.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

What is CALQUENCE?

CALQUENCE is a prescription medicine used to treat adults with mantle cell lymphoma (MCL) who have received at least one prior treatment for their cancer.

It is not known if CALQUENCE is safe and effective in children.

Please see complete Prescribing Information including Patient Information.